ClinicalTrials.gg
Not yet recruitingNCT06244966Updated Apr 10, 2024

GUM Remote Testing v4.0

An interventional study of HIV diagnostic testing in HIV Infections, Syphilis Infection and Hepatitis B and Hepatitis C, sponsored by Royal Devon and Exeter NHS Foundation Trust. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-10.

Sponsored by Royal Devon and Exeter NHS Foundation Trust · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Capillary blood sample results are compared to venous blood results

Read the detailed description

Capillary blood samples can be taken by patients from their own finger without requiring a healthcare professional to take a blood sample. Samples taken this way can be posted from home. This crucially avoids visits to the clinic or hospital to have blood samples taken. It would reduce the burden on healthcare professionals and is often preferred by patients. It is important to demonstrate that the results of an analysis performed on capillary blood samples are equivalent to the analysis of a standard venous sample.

This study aims to collect, in parallel to a standard venous blood sample, a capillary blood sample taken by the participant which is then added to specially designed filter paper (dried plasma spot sample) or other collection devices. Parallel analysis of paired samples will then allow the investigators to assess if results measured in samples taken using the two methods are similar.

The investigators will recruit 40 participants for each collection device to this study. It is important to obtain a range of positive and negative results from the study participants, and from stored samples and quality control material.

02

Conditions studied

  • HIV Infections
  • Syphilis Infection
  • Hepatitis B and Hepatitis C
03

In context

HIV Infections

4,734 studies on the registry are indexed under HIV Infections; 244 are open to participants now.

This study's planned enrollment of 40 is below the median of 80 across 3,489 interventional studies indexed under HIV Infections.

Browse HIV Infections studies →

Lead sponsor

Royal Devon and Exeter NHS Foundation Trust is the lead sponsor of 63 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults
  • Able and willing to provide .
  • Already having a venous blood sample for clinical care

Exclusion criteria

Exclusion Criteria:

  • Failure to consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Any client attending clinic for venous blood sampling

    Any client attending clinic for venous blood sampling for sexually transmitted disease diagnostics will also collect capillary blood using a finger prick

    Diagnostic Test: HIV diagnostic testing

Interventions

  • Diagnostic testHIV diagnostic testing

    Finger-prick capillary blood will be tested alongside venous blood

    Also known as: Syphilis diagnostic testing, Hepatitis diagnostic testing

06

What researchers measure

Primary outcomes

  1. Comparative capillary and venous samples screening testing

    To have sufficient parallel samples (capillary and venous) collected to demonstrate equivalence of the results of HIV, HBV, HCV and syphilis testing using the Roche Cobas e601 platform

    Time frame: 1 year

Secondary outcomes

  1. Comparative capillary and venous samples confirmatory testing

    To have sufficient parallel samples (capillary and venous) collected to demonstrate equivalence of the results of HIV, HBV, HCV and syphilis testing using other platforms and for viral load

    Time frame: 1 year

07

Study locations

1 site
  • Royal Devon University Hospital NHS Foundation Trust
    Exeter, Devon EX2 5AD, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — No data will be shared

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06244966
Lead sponsor
Royal Devon and Exeter NHS Foundation Trust
Responsible party
Sponsor
First posted
Feb 6, 2024
Start date
May 2024 (estimated)
Primary completion
May 2025 (estimated)
Completion
May 2025 (estimated)
Last update
Apr 10, 2024

Study contacts

Cressida Auckland
Contact
cressida.auckland@nhs.net
01392 406459
Alison Kerridge
Contact
rduh.research-eastern@nhs.net
01392 403055

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion